D. E. Shaw & Co., Inc. Catalent, Inc. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Catalent, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 364,543 shares of CTLT stock, worth $22.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

364,543

Holding current value

$22.2 Million

% of portfolio

0.02%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$56.16 - $60.96 $5.82 Million - $6.32 Million	103,650 Added 39.73%	364,543 $22.1 Million
Q2 2024 Aug 14, 2024	BUY	$53.58 - $57.02 $14 Million - $14.9 Million	260,893 New	260,893 $14.7 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $16.5 Million - $23.9 Million	513,300 New	513,300 $23.1 Million
Q2 2023 Aug 14, 2023	SELL	$31.86 - $67.26 $9.23 Million - $19.5 Million	-289,685 Reduced 54.23%	244,505 $10.6 Million
Q1 2023 May 15, 2023	SELL	$45.44 - $74.26 $31.2 Million - $50.9 Million	-685,682 Reduced 56.21%	534,190 $35.1 Million
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $50.5 Million - $98.8 Million	1,219,872 New	1,219,872 $54.9 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $11.7 Million - $15.4 Million	-134,661 Reduced 91.56%	12,411 $1.33 Million
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $10.7 Million - $14.2 Million	-113,706 Reduced 43.6%	147,072 $16.3 Million
Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $5.04 Million - $5.86 Million	-42,140 Reduced 13.91%	260,778 $33.4 Million
Q3 2021 Nov 15, 2021	SELL	$109.17 - $142.35 $9.76 Million - $12.7 Million	-89,378 Reduced 22.78%	302,918 $40.3 Million
Q2 2021 Aug 16, 2021	SELL	$100.34 - $115.69 $17 Million - $19.6 Million	-169,791 Reduced 30.21%	392,296 $42.4 Million
Q1 2021 May 17, 2021	BUY	$101.51 - $125.27 $27 Million - $33.3 Million	265,648 Added 89.61%	562,087 $59.2 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $5.1 Million - $6.25 Million	59,363 Added 25.04%	296,439 $30.9 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $3.77 Million - $4.8 Million	51,893 Added 28.02%	237,076 $20.3 Million
Q2 2020 Aug 14, 2020	SELL	$48.02 - $79.04 $6.62 Million - $10.9 Million	-137,814 Reduced 42.67%	185,183 $13.6 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $16.8 Million - $28.7 Million	-455,907 Reduced 58.53%	322,997 $16.8 Million
Q4 2019 Feb 14, 2020	SELL	$47.06 - $56.64 $7.26 Million - $8.74 Million	-154,349 Reduced 16.54%	778,904 $43.9 Million
Q3 2019 Nov 14, 2019	BUY	$47.45 - $58.05 $12.6 Million - $15.4 Million	265,946 Added 39.85%	933,253 $44.5 Million
Q2 2019 Aug 14, 2019	SELL	$39.26 - $54.21 $13.9 Million - $19.2 Million	-354,566 Reduced 34.7%	667,307 $36.2 Million
Q1 2019 May 15, 2019	SELL	$29.84 - $43.92 $40.2 Million - $59.2 Million	-1,347,357 Reduced 56.87%	1,021,873 $41.5 Million
Q4 2018 Feb 14, 2019	BUY	$29.95 - $46.34 $19.9 Million - $30.8 Million	665,326 Added 39.05%	2,369,230 $73.9 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $33.2 Million - $37.7 Million	827,217 Added 94.36%	1,703,904 $77.6 Million
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $31 Million - $34 Million	800,509 Added 1050.84%	876,687 $36.7 Million
Q1 2018 May 15, 2018	SELL	$39.4 - $47.39 $12.1 Million - $14.6 Million	-307,900 Reduced 80.17%	76,178 $3.13 Million
Q4 2017 Feb 14, 2018	SELL	$37.27 - $43.02 $6.92 Million - $7.99 Million	-185,659 Reduced 32.59%	384,078 $15.8 Million
Q3 2017 Nov 14, 2017	BUY	$33.75 - $41.67 $19.2 Million - $23.7 Million	569,737	569,737 $22.7 Million

Others Institutions Holding CTLT

# of Institutions

513

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account